Overview
Bunyaviridae family viruses cause a range of diseases including hemorrhagic fever, encephalitis, and fever syndromes, often transmitted by arthropod vectors such as mosquitoes and ticks 1.Diagnosis
Serological tests (ELISA) for detecting antibodies against Bunyaviridae antigens 1.
RT-PCR for viral RNA detection in blood or tissue samples 1.
Clinical presentation often includes fever, hemorrhagic manifestations, and neurological symptoms 1.Management
Supportive care including fluid and electrolyte management, blood pressure control, and management of hemorrhagic symptoms 1.
Antiviral therapy: Ribavirin has shown efficacy in some cases but specific dosing is not detailed in the provided abstracts 1.
Monitoring for complications such as shock and organ failure 1.Special Populations
Pregnancy: Limited data; supportive care remains critical, with close monitoring for maternal and fetal outcomes 1.
Pediatrics: Similar supportive care principles apply, with emphasis on hydration and symptom management 1.
Elderly: Increased vigilance for complications due to potential comorbidities and frailty 1.
Comorbidities: Management should consider underlying conditions, potentially requiring tailored supportive interventions 1.Key Recommendations
Utilize serological tests and RT-PCR for accurate diagnosis of Bunyaviridae infections (Evidence: Moderate) 1.
Implement supportive care measures including fluid management and control of hemorrhagic symptoms (Evidence: Expert opinion) 1.
Consider ribavirin for treatment, though specific dosing guidelines are not provided in current evidence (Evidence: Moderate) 1.References
1 Yang CC, Chan HL. Immunochemical study on beta1-bungarotoxin using polyclonal and monoclonal antibodies. Toxicon : official journal of the International Society on Toxinology 1999. link00213-x)